Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01364129 · ClinicalTrials.gov registry record · NA

The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy

A NA study of Diabetic Retinopathy, sponsored by Legacy Health System.

Completed
Registry status
NA
Development phase
567
Enrollment target
2
Study locations

NCT01364129 is a NA study of Diabetic Retinopathy that has completed, run by Legacy Health System. The registered enrollment target is 567 participants, below the 1,666-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01364129, a NA study of Diabetic Retinopathy, has completed, sponsored by Legacy Health System.

COMPLETED
Registry status
NA
Development phase
567 participants
Enrollment target
2
Study locations

Study Summary

This project aims to: 1) evaluate the long-term effectiveness of telemedicine to detect diabetic retinopathy when compared to traditional surveillance methods, 2) identify the health belief factors related to adherence with annual diabetic eye exams, and 3) determine the cost-effectiveness of the telemedicine system from the perspective of the community clinic, the third-party payer, and the individual patient.

Conditions Studied

Interventions

  • PROCEDURE Ophthalmic Telemedicine

Study Locations (2)

Kansas

  • Hunter Health Clinic - Wichita

Oregon

  • Yellowhawk Tribal Health Center - Pendleton

Trial Details

FieldValue
Enrollment Target 567 participants
Start Date 2006-08
Est. Completion 2012-06
Phase NA

Sponsor

Legacy Health System

21 total trials

What the Registry Record Tells You About NCT01364129

The ClinicalTrials.gov registry entry for NCT01364129 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 567 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,666-participant average among 57 other Diabetic Retinopathy trials with a reported enrollment target (66% lower). The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetic Retinopathy appearing as the primary indexed condition, and to 1 intervention - of which Ophthalmic Telemedicine is the first listed.

NCT01364129 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Oregon.

Frequently Asked Questions

What is clinical trial NCT01364129 about?

NCT01364129 is a clinical study titled "The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy". This project aims to: 1) evaluate the long-term effectiveness of telemedicine to detect diabetic retinopathy when compared to traditional surveillance methods, 2) identify the health belief factors related to adherence with annual diabetic eye exams, and 3) determine the cost-effectiveness of the te...

What is the current status of trial NCT01364129?

This trial is currently completed. It is a NA study. The enrollment target is 567 participants. The study started on 2006-08. Estimated completion is 2012-06.

What conditions does trial NCT01364129 study?

This clinical trial studies the following conditions: Diabetic Retinopathy.

What interventions are being tested in trial NCT01364129?

The interventions under investigation include: Ophthalmic Telemedicine (PROCEDURE).

Who is sponsoring clinical trial NCT01364129?

This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01364129 being conducted?

This trial has 2 study locations across Kansas, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetic Retinopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.